Antimitotic agents: synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamates.
Antimitotic agents: synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamates.
复制标题
抗有丝分裂剂:咪唑并[4,5-c]吡啶-6-基氨基甲酸酯和咪唑并[4,5-b]吡啶-5-基氨基甲酸酯的合成。
DOI:
10.1021/jm00164a030
复制
发表时间:
1990
影响因子:
7.3
通讯作者:
TempleJr,C
中科院分区:
文献类型:
--
作者:
TempleJr,C
6] pyrazines (1), also have shown anticancer activity. 1-3 The 1, 2-NHCH moiety of 1 is unstable and oxidation provides inactive heteroaromatic compounds. In a previous paper we reported the synthesis of some 2-aryl-1H-imidazo [4, 5-c] pyridin-6-ylcarbamates (eg, 2) as more stable ring analogues of 1 (Chart I). 1 234* Although many of the structural featuresnecessary for activity in 1 were incorporated in 2, the imidazopyridines showed only minimal activity. The lower activity was attributed to the lack of basicity at the ring NH group, and possibly to the differences in orientation of the aryl groups of 1 and 2. In this paper we report the preparation of 1-amino-lii-imidazo [4, 5-c] pyridines substituted at the 2-position with the more flexible benzylthio moiety. Also, this work provided some new derivatives of the imidazo [4, 5-61-pyridine ring system.